SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-039272
Filing Date
2020-03-27
Accepted
2020-03-27 08:31:27
Documents
59
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm205377d1_10k.htm 10-K 1202344
2 EXHIBIT 4.1 tm205377d1_ex4-1.htm EX-4.1 21611
3 EXHIBIT 21.1 tm205377d1_ex21-1.htm EX-21.1 2475
4 EXHIBIT 23.1 tm205377d1_ex23-1.htm EX-23.1 3009
5 EXHIBIT 31.1 tm205377d1_ex31-1.htm EX-31.1 7922
6 EXHIBIT 31.2 tm205377d1_ex31-2.htm EX-31.2 7798
7 EXHIBIT 32.1 tm205377d1_ex32-1.htm EX-32.1 4544
8 EXHIBIT 32.2 tm205377d1_ex32-2.htm EX-32.2 4602
  Complete submission text file 0001104659-20-039272.txt   5597154

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT capr-20191231.xml EX-101.INS 1196204
10 XBRL TAXONOMY EXTENSION SCHEMA capr-20191231.xsd EX-101.SCH 48342
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20191231_cal.xml EX-101.CAL 34738
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20191231_def.xml EX-101.DEF 172756
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20191231_lab.xml EX-101.LAB 359841
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20191231_pre.xml EX-101.PRE 311124
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34058 | Film No.: 20748142
SIC: 2834 Pharmaceutical Preparations